nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Azacitidine—Cladribine—multiple sclerosis	0.0134	1	CbGdCrCtD
Pentazocine—OPRM1—nerve—multiple sclerosis	0.0069	0.177	CbGeAlD
Pentazocine—Euphoric mood—Dexamethasone—multiple sclerosis	0.00344	0.00538	CcSEcCtD
Pentazocine—Euphoric mood—Betamethasone—multiple sclerosis	0.00344	0.00538	CcSEcCtD
Pentazocine—Apnoea—Methotrexate—multiple sclerosis	0.00344	0.00538	CcSEcCtD
Pentazocine—Erythema multiforme—Azathioprine—multiple sclerosis	0.00344	0.00538	CcSEcCtD
Pentazocine—Chills—Azathioprine—multiple sclerosis	0.00326	0.0051	CcSEcCtD
Pentazocine—Confusional state—Cladribine—multiple sclerosis	0.0032	0.00501	CcSEcCtD
Pentazocine—Sweating—Mitoxantrone—multiple sclerosis	0.00314	0.00491	CcSEcCtD
Pentazocine—Tachycardia—Cladribine—multiple sclerosis	0.0031	0.00485	CcSEcCtD
Pentazocine—Ulcer—Methotrexate—multiple sclerosis	0.00308	0.00482	CcSEcCtD
Pentazocine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00307	0.0048	CcSEcCtD
Pentazocine—Visual disturbance—Betamethasone—multiple sclerosis	0.00307	0.0048	CcSEcCtD
Pentazocine—Visual disturbance—Dexamethasone—multiple sclerosis	0.00307	0.0048	CcSEcCtD
Pentazocine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00306	0.00478	CcSEcCtD
Pentazocine—Irritability—Methylprednisolone—multiple sclerosis	0.00305	0.00477	CcSEcCtD
Pentazocine—Anorexia—Cladribine—multiple sclerosis	0.00303	0.00474	CcSEcCtD
Pentazocine—Euphoric mood—Prednisone—multiple sclerosis	0.003	0.00469	CcSEcCtD
Pentazocine—Hypotension—Cladribine—multiple sclerosis	0.00297	0.00464	CcSEcCtD
Pentazocine—OPRM1—brainstem—multiple sclerosis	0.00296	0.0759	CbGeAlD
Pentazocine—Sweating increased—Prednisolone—multiple sclerosis	0.00293	0.00459	CcSEcCtD
Pentazocine—Insomnia—Cladribine—multiple sclerosis	0.00287	0.00449	CcSEcCtD
Pentazocine—Paraesthesia—Cladribine—multiple sclerosis	0.00285	0.00446	CcSEcCtD
Pentazocine—Dyspnoea—Cladribine—multiple sclerosis	0.00283	0.00443	CcSEcCtD
Pentazocine—Somnolence—Cladribine—multiple sclerosis	0.00282	0.00442	CcSEcCtD
Pentazocine—Irritability—Dexamethasone—multiple sclerosis	0.00278	0.00434	CcSEcCtD
Pentazocine—Irritability—Betamethasone—multiple sclerosis	0.00278	0.00434	CcSEcCtD
Pentazocine—Decreased appetite—Cladribine—multiple sclerosis	0.00276	0.00432	CcSEcCtD
Pentazocine—Constipation—Cladribine—multiple sclerosis	0.00272	0.00425	CcSEcCtD
Pentazocine—Sweating increased—Triamcinolone—multiple sclerosis	0.0027	0.00422	CcSEcCtD
Pentazocine—Sweating increased—Methylprednisolone—multiple sclerosis	0.00269	0.00421	CcSEcCtD
Pentazocine—Chills—Mitoxantrone—multiple sclerosis	0.00264	0.00412	CcSEcCtD
Pentazocine—Feeling abnormal—Cladribine—multiple sclerosis	0.00262	0.00409	CcSEcCtD
Pentazocine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00251	0.00392	CcSEcCtD
Pentazocine—Sweating increased—Dexamethasone—multiple sclerosis	0.00245	0.00383	CcSEcCtD
Pentazocine—Sweating increased—Betamethasone—multiple sclerosis	0.00245	0.00383	CcSEcCtD
Pentazocine—Face oedema—Prednisone—multiple sclerosis	0.00245	0.00382	CcSEcCtD
Pentazocine—Irritability—Prednisone—multiple sclerosis	0.00242	0.00378	CcSEcCtD
Pentazocine—Hypotension—Azathioprine—multiple sclerosis	0.00241	0.00378	CcSEcCtD
Pentazocine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00241	0.00377	CcSEcCtD
Pentazocine—Sweating—Methylprednisolone—multiple sclerosis	0.00236	0.0037	CcSEcCtD
Pentazocine—Hypersensitivity—Cladribine—multiple sclerosis	0.00234	0.00366	CcSEcCtD
Pentazocine—Visual impairment—Prednisolone—multiple sclerosis	0.00232	0.00363	CcSEcCtD
Pentazocine—Asthenia—Cladribine—multiple sclerosis	0.00228	0.00356	CcSEcCtD
Pentazocine—OPRD1—nervous system—multiple sclerosis	0.00228	0.0583	CbGeAlD
Pentazocine—Pruritus—Cladribine—multiple sclerosis	0.00225	0.00352	CcSEcCtD
Pentazocine—Visual disturbance—Methotrexate—multiple sclerosis	0.00223	0.00349	CcSEcCtD
Pentazocine—Hypertension—Mitoxantrone—multiple sclerosis	0.00221	0.00345	CcSEcCtD
Pentazocine—Hallucination—Methylprednisolone—multiple sclerosis	0.0022	0.00344	CcSEcCtD
Pentazocine—OPRD1—central nervous system—multiple sclerosis	0.00219	0.0562	CbGeAlD
Pentazocine—OPRK1—nervous system—multiple sclerosis	0.00218	0.0559	CbGeAlD
Pentazocine—Diarrhoea—Cladribine—multiple sclerosis	0.00217	0.0034	CcSEcCtD
Pentazocine—Sweating increased—Prednisone—multiple sclerosis	0.00213	0.00334	CcSEcCtD
Pentazocine—Visual impairment—Methylprednisolone—multiple sclerosis	0.00213	0.00333	CcSEcCtD
Pentazocine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00213	0.00333	CcSEcCtD
Pentazocine—Confusional state—Mitoxantrone—multiple sclerosis	0.00211	0.00329	CcSEcCtD
Pentazocine—OPRK1—central nervous system—multiple sclerosis	0.0021	0.0538	CbGeAlD
Pentazocine—Dizziness—Cladribine—multiple sclerosis	0.0021	0.00329	CcSEcCtD
Pentazocine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00209	0.00327	CcSEcCtD
Pentazocine—Shock—Mitoxantrone—multiple sclerosis	0.00205	0.00321	CcSEcCtD
Pentazocine—OPRK1—cerebellum—multiple sclerosis	0.00205	0.0526	CbGeAlD
Pentazocine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00204	0.00319	CcSEcCtD
Pentazocine—Irritability—Methotrexate—multiple sclerosis	0.00202	0.00316	CcSEcCtD
Pentazocine—Vomiting—Cladribine—multiple sclerosis	0.00202	0.00316	CcSEcCtD
Pentazocine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00202	0.00316	CcSEcCtD
Pentazocine—Hallucination—Dexamethasone—multiple sclerosis	0.002	0.00313	CcSEcCtD
Pentazocine—Hallucination—Betamethasone—multiple sclerosis	0.002	0.00313	CcSEcCtD
Pentazocine—Dermatitis—Cladribine—multiple sclerosis	0.002	0.00313	CcSEcCtD
Pentazocine—Anorexia—Mitoxantrone—multiple sclerosis	0.00199	0.00311	CcSEcCtD
Pentazocine—Headache—Cladribine—multiple sclerosis	0.00199	0.00311	CcSEcCtD
Pentazocine—Vision blurred—Prednisolone—multiple sclerosis	0.00198	0.00309	CcSEcCtD
Pentazocine—Hypotension—Mitoxantrone—multiple sclerosis	0.00195	0.00305	CcSEcCtD
Pentazocine—Visual impairment—Betamethasone—multiple sclerosis	0.00194	0.00303	CcSEcCtD
Pentazocine—Visual impairment—Dexamethasone—multiple sclerosis	0.00194	0.00303	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00191	0.00298	CcSEcCtD
Pentazocine—Hypersensitivity—Azathioprine—multiple sclerosis	0.0019	0.00298	CcSEcCtD
Pentazocine—Dysgeusia—Triamcinolone—multiple sclerosis	0.00189	0.00296	CcSEcCtD
Pentazocine—OPRM1—midbrain—multiple sclerosis	0.00189	0.0484	CbGeAlD
Pentazocine—Nausea—Cladribine—multiple sclerosis	0.00189	0.00295	CcSEcCtD
Pentazocine—Vertigo—Prednisolone—multiple sclerosis	0.00189	0.00295	CcSEcCtD
Pentazocine—Syncope—Prednisolone—multiple sclerosis	0.00188	0.00294	CcSEcCtD
Pentazocine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00187	0.00293	CcSEcCtD
Pentazocine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00186	0.00291	CcSEcCtD
Pentazocine—Somnolence—Mitoxantrone—multiple sclerosis	0.00186	0.0029	CcSEcCtD
Pentazocine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00184	0.00289	CcSEcCtD
Pentazocine—OPRM1—spinal cord—multiple sclerosis	0.00184	0.0472	CbGeAlD
Pentazocine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00182	0.00284	CcSEcCtD
Pentazocine—Hypertension—Prednisolone—multiple sclerosis	0.00181	0.00283	CcSEcCtD
Pentazocine—Eosinophilia—Methotrexate—multiple sclerosis	0.00181	0.00283	CcSEcCtD
Pentazocine—Constipation—Mitoxantrone—multiple sclerosis	0.00179	0.00279	CcSEcCtD
Pentazocine—Diarrhoea—Azathioprine—multiple sclerosis	0.00177	0.00276	CcSEcCtD
Pentazocine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00175	0.00274	CcSEcCtD
Pentazocine—Hallucination—Prednisone—multiple sclerosis	0.00174	0.00273	CcSEcCtD
Pentazocine—OPRD1—brain—multiple sclerosis	0.00174	0.0446	CbGeAlD
Pentazocine—Vertigo—Triamcinolone—multiple sclerosis	0.00173	0.00271	CcSEcCtD
Pentazocine—Syncope—Triamcinolone—multiple sclerosis	0.00173	0.00271	CcSEcCtD
Pentazocine—Vertigo—Methylprednisolone—multiple sclerosis	0.00173	0.00271	CcSEcCtD
Pentazocine—Syncope—Methylprednisolone—multiple sclerosis	0.00173	0.0027	CcSEcCtD
Pentazocine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00172	0.00269	CcSEcCtD
Pentazocine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00171	0.00268	CcSEcCtD
Pentazocine—Dizziness—Azathioprine—multiple sclerosis	0.00171	0.00267	CcSEcCtD
Pentazocine—SIGMAR1—medulla oblongata—multiple sclerosis	0.00171	0.0437	CbGeAlD
Pentazocine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.0017	0.00265	CcSEcCtD
Pentazocine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00169	0.00265	CcSEcCtD
Pentazocine—Shock—Prednisolone—multiple sclerosis	0.00169	0.00264	CcSEcCtD
Pentazocine—Tachycardia—Prednisolone—multiple sclerosis	0.00167	0.00261	CcSEcCtD
Pentazocine—OPRK1—brain—multiple sclerosis	0.00167	0.0427	CbGeAlD
Pentazocine—Hypertension—Triamcinolone—multiple sclerosis	0.00167	0.00261	CcSEcCtD
Pentazocine—Hypertension—Methylprednisolone—multiple sclerosis	0.00166	0.0026	CcSEcCtD
Pentazocine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00166	0.00259	CcSEcCtD
Pentazocine—Vomiting—Azathioprine—multiple sclerosis	0.00164	0.00257	CcSEcCtD
Pentazocine—Dermatitis—Azathioprine—multiple sclerosis	0.00163	0.00254	CcSEcCtD
Pentazocine—Flushing—Prednisone—multiple sclerosis	0.00163	0.00254	CcSEcCtD
Pentazocine—Headache—Azathioprine—multiple sclerosis	0.00162	0.00253	CcSEcCtD
Pentazocine—Dry mouth—Triamcinolone—multiple sclerosis	0.00161	0.00251	CcSEcCtD
Pentazocine—Confusional state—Methylprednisolone—multiple sclerosis	0.00158	0.00248	CcSEcCtD
Pentazocine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00158	0.00246	CcSEcCtD
Pentazocine—Vertigo—Betamethasone—multiple sclerosis	0.00157	0.00246	CcSEcCtD
Pentazocine—Vertigo—Dexamethasone—multiple sclerosis	0.00157	0.00246	CcSEcCtD
Pentazocine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00157	0.00246	CcSEcCtD
Pentazocine—Syncope—Dexamethasone—multiple sclerosis	0.00157	0.00246	CcSEcCtD
Pentazocine—Syncope—Betamethasone—multiple sclerosis	0.00157	0.00246	CcSEcCtD
Pentazocine—Sweating—Methotrexate—multiple sclerosis	0.00156	0.00245	CcSEcCtD
Pentazocine—SIGMAR1—midbrain—multiple sclerosis	0.00156	0.04	CbGeAlD
Pentazocine—OPRM1—nervous system—multiple sclerosis	0.00155	0.0398	CbGeAlD
Pentazocine—Shock—Triamcinolone—multiple sclerosis	0.00155	0.00242	CcSEcCtD
Pentazocine—Insomnia—Prednisolone—multiple sclerosis	0.00155	0.00242	CcSEcCtD
Pentazocine—Shock—Methylprednisolone—multiple sclerosis	0.00155	0.00242	CcSEcCtD
Pentazocine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00154	0.00241	CcSEcCtD
Pentazocine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00154	0.00241	CcSEcCtD
Pentazocine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00154	0.00241	CcSEcCtD
Pentazocine—Paraesthesia—Prednisolone—multiple sclerosis	0.00154	0.00241	CcSEcCtD
Pentazocine—Tachycardia—Triamcinolone—multiple sclerosis	0.00154	0.0024	CcSEcCtD
Pentazocine—Nausea—Azathioprine—multiple sclerosis	0.00153	0.0024	CcSEcCtD
Pentazocine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00153	0.0024	CcSEcCtD
Pentazocine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00152	0.00238	CcSEcCtD
Pentazocine—Agranulocytosis—Methotrexate—multiple sclerosis	0.00152	0.00238	CcSEcCtD
Pentazocine—SIGMAR1—spinal cord—multiple sclerosis	0.00152	0.039	CbGeAlD
Pentazocine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00152	0.00238	CcSEcCtD
Pentazocine—Hypertension—Dexamethasone—multiple sclerosis	0.00151	0.00237	CcSEcCtD
Pentazocine—Hypertension—Betamethasone—multiple sclerosis	0.00151	0.00237	CcSEcCtD
Pentazocine—Asthenia—Mitoxantrone—multiple sclerosis	0.0015	0.00234	CcSEcCtD
Pentazocine—OPRM1—central nervous system—multiple sclerosis	0.00149	0.0383	CbGeAlD
Pentazocine—Hypotension—Methylprednisolone—multiple sclerosis	0.00147	0.0023	CcSEcCtD
Pentazocine—Vision blurred—Prednisone—multiple sclerosis	0.00144	0.00225	CcSEcCtD
Pentazocine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00143	0.00224	CcSEcCtD
Pentazocine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00143	0.00224	CcSEcCtD
Pentazocine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00143	0.00223	CcSEcCtD
Pentazocine—Insomnia—Triamcinolone—multiple sclerosis	0.00142	0.00223	CcSEcCtD
Pentazocine—Insomnia—Methylprednisolone—multiple sclerosis	0.00142	0.00222	CcSEcCtD
Pentazocine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00141	0.00221	CcSEcCtD
Pentazocine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00141	0.00221	CcSEcCtD
Pentazocine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00141	0.00221	CcSEcCtD
Pentazocine—Visual impairment—Methotrexate—multiple sclerosis	0.00141	0.00221	CcSEcCtD
Pentazocine—Shock—Dexamethasone—multiple sclerosis	0.00141	0.0022	CcSEcCtD
Pentazocine—Shock—Betamethasone—multiple sclerosis	0.00141	0.0022	CcSEcCtD
Pentazocine—Dyspnoea—Triamcinolone—multiple sclerosis	0.0014	0.0022	CcSEcCtD
Pentazocine—Agitation—Prednisone—multiple sclerosis	0.0014	0.00219	CcSEcCtD
Pentazocine—Tachycardia—Betamethasone—multiple sclerosis	0.0014	0.00218	CcSEcCtD
Pentazocine—Tachycardia—Dexamethasone—multiple sclerosis	0.0014	0.00218	CcSEcCtD
Pentazocine—Erythema multiforme—Methotrexate—multiple sclerosis	0.00138	0.00217	CcSEcCtD
Pentazocine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00138	0.00216	CcSEcCtD
Pentazocine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00138	0.00216	CcSEcCtD
Pentazocine—Vertigo—Prednisone—multiple sclerosis	0.00137	0.00214	CcSEcCtD
Pentazocine—Syncope—Prednisone—multiple sclerosis	0.00137	0.00214	CcSEcCtD
Pentazocine—Tinnitus—Methotrexate—multiple sclerosis	0.00137	0.00214	CcSEcCtD
Pentazocine—Anorexia—Dexamethasone—multiple sclerosis	0.00136	0.00213	CcSEcCtD
Pentazocine—Anorexia—Betamethasone—multiple sclerosis	0.00136	0.00213	CcSEcCtD
Pentazocine—Loss of consciousness—Prednisone—multiple sclerosis	0.00134	0.0021	CcSEcCtD
Pentazocine—Hypotension—Betamethasone—multiple sclerosis	0.00134	0.00209	CcSEcCtD
Pentazocine—Hypotension—Dexamethasone—multiple sclerosis	0.00134	0.00209	CcSEcCtD
Pentazocine—Vomiting—Mitoxantrone—multiple sclerosis	0.00133	0.00208	CcSEcCtD
Pentazocine—Hypertension—Prednisone—multiple sclerosis	0.00132	0.00206	CcSEcCtD
Pentazocine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00132	0.00206	CcSEcCtD
Pentazocine—Chills—Methotrexate—multiple sclerosis	0.00131	0.00206	CcSEcCtD
Pentazocine—Headache—Mitoxantrone—multiple sclerosis	0.00131	0.00205	CcSEcCtD
Pentazocine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.0013	0.00203	CcSEcCtD
Pentazocine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0013	0.00203	CcSEcCtD
Pentazocine—Insomnia—Dexamethasone—multiple sclerosis	0.00129	0.00202	CcSEcCtD
Pentazocine—Insomnia—Betamethasone—multiple sclerosis	0.00129	0.00202	CcSEcCtD
Pentazocine—Paraesthesia—Betamethasone—multiple sclerosis	0.00128	0.00201	CcSEcCtD
Pentazocine—Paraesthesia—Dexamethasone—multiple sclerosis	0.00128	0.00201	CcSEcCtD
Pentazocine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00126	0.00197	CcSEcCtD
Pentazocine—Dysgeusia—Methotrexate—multiple sclerosis	0.00125	0.00195	CcSEcCtD
Pentazocine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00124	0.00195	CcSEcCtD
Pentazocine—Decreased appetite—Betamethasone—multiple sclerosis	0.00124	0.00194	CcSEcCtD
Pentazocine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00124	0.00194	CcSEcCtD
Pentazocine—Nausea—Mitoxantrone—multiple sclerosis	0.00124	0.00194	CcSEcCtD
Pentazocine—Shock—Prednisone—multiple sclerosis	0.00122	0.00192	CcSEcCtD
Pentazocine—Tachycardia—Prednisone—multiple sclerosis	0.00121	0.0019	CcSEcCtD
Pentazocine—SIGMAR1—cerebellum—multiple sclerosis	0.00121	0.0309	CbGeAlD
Pentazocine—Hyperhidrosis—Prednisone—multiple sclerosis	0.0012	0.00188	CcSEcCtD
Pentazocine—Vision blurred—Methotrexate—multiple sclerosis	0.0012	0.00188	CcSEcCtD
Pentazocine—Anorexia—Prednisone—multiple sclerosis	0.00119	0.00186	CcSEcCtD
Pentazocine—OPRM1—brain—multiple sclerosis	0.00119	0.0304	CbGeAlD
Pentazocine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00118	0.00184	CcSEcCtD
Pentazocine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00118	0.00184	CcSEcCtD
Pentazocine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00116	0.00182	CcSEcCtD
Pentazocine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00116	0.00181	CcSEcCtD
Pentazocine—Vertigo—Methotrexate—multiple sclerosis	0.00115	0.00179	CcSEcCtD
Pentazocine—Dizziness—Prednisolone—multiple sclerosis	0.00113	0.00177	CcSEcCtD
Pentazocine—Asthenia—Triamcinolone—multiple sclerosis	0.00113	0.00177	CcSEcCtD
Pentazocine—Asthenia—Methylprednisolone—multiple sclerosis	0.00113	0.00176	CcSEcCtD
Pentazocine—Insomnia—Prednisone—multiple sclerosis	0.00113	0.00176	CcSEcCtD
Pentazocine—Paraesthesia—Prednisone—multiple sclerosis	0.00112	0.00175	CcSEcCtD
Pentazocine—Pruritus—Triamcinolone—multiple sclerosis	0.00111	0.00174	CcSEcCtD
Pentazocine—Pruritus—Methylprednisolone—multiple sclerosis	0.00111	0.00174	CcSEcCtD
Pentazocine—Decreased appetite—Prednisone—multiple sclerosis	0.00108	0.00169	CcSEcCtD
Pentazocine—Dermatitis—Prednisolone—multiple sclerosis	0.00108	0.00169	CcSEcCtD
Pentazocine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00108	0.00168	CcSEcCtD
Pentazocine—Headache—Prednisolone—multiple sclerosis	0.00107	0.00168	CcSEcCtD
Pentazocine—Constipation—Prednisone—multiple sclerosis	0.00106	0.00166	CcSEcCtD
Pentazocine—Confusional state—Methotrexate—multiple sclerosis	0.00105	0.00164	CcSEcCtD
Pentazocine—Dizziness—Triamcinolone—multiple sclerosis	0.00104	0.00163	CcSEcCtD
Pentazocine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00104	0.00163	CcSEcCtD
Pentazocine—Dizziness—Methylprednisolone—multiple sclerosis	0.00104	0.00163	CcSEcCtD
Pentazocine—Feeling abnormal—Prednisone—multiple sclerosis	0.00103	0.0016	CcSEcCtD
Pentazocine—Asthenia—Dexamethasone—multiple sclerosis	0.00103	0.0016	CcSEcCtD
Pentazocine—Asthenia—Betamethasone—multiple sclerosis	0.00103	0.0016	CcSEcCtD
Pentazocine—Nausea—Prednisolone—multiple sclerosis	0.00102	0.00159	CcSEcCtD
Pentazocine—Pruritus—Betamethasone—multiple sclerosis	0.00101	0.00158	CcSEcCtD
Pentazocine—Pruritus—Dexamethasone—multiple sclerosis	0.00101	0.00158	CcSEcCtD
Pentazocine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00101	0.00157	CcSEcCtD
Pentazocine—Vomiting—Triamcinolone—multiple sclerosis	0.001	0.00157	CcSEcCtD
Pentazocine—Vomiting—Methylprednisolone—multiple sclerosis	0.000999	0.00156	CcSEcCtD
Pentazocine—Dermatitis—Triamcinolone—multiple sclerosis	0.000992	0.00155	CcSEcCtD
Pentazocine—Anorexia—Methotrexate—multiple sclerosis	0.000992	0.00155	CcSEcCtD
Pentazocine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00099	0.00155	CcSEcCtD
Pentazocine—Headache—Triamcinolone—multiple sclerosis	0.000987	0.00154	CcSEcCtD
Pentazocine—Headache—Methylprednisolone—multiple sclerosis	0.000985	0.00154	CcSEcCtD
Pentazocine—SIGMAR1—brain—multiple sclerosis	0.00098	0.0251	CbGeAlD
Pentazocine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000978	0.00153	CcSEcCtD
Pentazocine—Diarrhoea—Betamethasone—multiple sclerosis	0.000978	0.00153	CcSEcCtD
Pentazocine—Hypotension—Methotrexate—multiple sclerosis	0.000972	0.00152	CcSEcCtD
Pentazocine—Dizziness—Betamethasone—multiple sclerosis	0.000945	0.00148	CcSEcCtD
Pentazocine—Dizziness—Dexamethasone—multiple sclerosis	0.000945	0.00148	CcSEcCtD
Pentazocine—Insomnia—Methotrexate—multiple sclerosis	0.000941	0.00147	CcSEcCtD
Pentazocine—Nausea—Triamcinolone—multiple sclerosis	0.000936	0.00146	CcSEcCtD
Pentazocine—Paraesthesia—Methotrexate—multiple sclerosis	0.000934	0.00146	CcSEcCtD
Pentazocine—Nausea—Methylprednisolone—multiple sclerosis	0.000934	0.00146	CcSEcCtD
Pentazocine—Dyspnoea—Methotrexate—multiple sclerosis	0.000928	0.00145	CcSEcCtD
Pentazocine—Somnolence—Methotrexate—multiple sclerosis	0.000925	0.00145	CcSEcCtD
Pentazocine—Hypersensitivity—Prednisone—multiple sclerosis	0.000917	0.00143	CcSEcCtD
Pentazocine—Vomiting—Betamethasone—multiple sclerosis	0.000909	0.00142	CcSEcCtD
Pentazocine—Vomiting—Dexamethasone—multiple sclerosis	0.000909	0.00142	CcSEcCtD
Pentazocine—Decreased appetite—Methotrexate—multiple sclerosis	0.000904	0.00141	CcSEcCtD
Pentazocine—Dermatitis—Dexamethasone—multiple sclerosis	0.0009	0.00141	CcSEcCtD
Pentazocine—Dermatitis—Betamethasone—multiple sclerosis	0.0009	0.00141	CcSEcCtD
Pentazocine—Headache—Betamethasone—multiple sclerosis	0.000895	0.0014	CcSEcCtD
Pentazocine—Headache—Dexamethasone—multiple sclerosis	0.000895	0.0014	CcSEcCtD
Pentazocine—Asthenia—Prednisone—multiple sclerosis	0.000893	0.0014	CcSEcCtD
Pentazocine—Pruritus—Prednisone—multiple sclerosis	0.000881	0.00138	CcSEcCtD
Pentazocine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000857	0.00134	CcSEcCtD
Pentazocine—Diarrhoea—Prednisone—multiple sclerosis	0.000852	0.00133	CcSEcCtD
Pentazocine—Nausea—Dexamethasone—multiple sclerosis	0.000849	0.00133	CcSEcCtD
Pentazocine—Nausea—Betamethasone—multiple sclerosis	0.000849	0.00133	CcSEcCtD
Pentazocine—Dizziness—Prednisone—multiple sclerosis	0.000823	0.00129	CcSEcCtD
Pentazocine—Vomiting—Prednisone—multiple sclerosis	0.000791	0.00124	CcSEcCtD
Pentazocine—Dermatitis—Prednisone—multiple sclerosis	0.000784	0.00123	CcSEcCtD
Pentazocine—Headache—Prednisone—multiple sclerosis	0.00078	0.00122	CcSEcCtD
Pentazocine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000766	0.0012	CcSEcCtD
Pentazocine—Asthenia—Methotrexate—multiple sclerosis	0.000746	0.00117	CcSEcCtD
Pentazocine—Nausea—Prednisone—multiple sclerosis	0.000739	0.00116	CcSEcCtD
Pentazocine—Pruritus—Methotrexate—multiple sclerosis	0.000736	0.00115	CcSEcCtD
Pentazocine—Diarrhoea—Methotrexate—multiple sclerosis	0.000712	0.00111	CcSEcCtD
Pentazocine—Dizziness—Methotrexate—multiple sclerosis	0.000688	0.00108	CcSEcCtD
Pentazocine—Vomiting—Methotrexate—multiple sclerosis	0.000661	0.00103	CcSEcCtD
Pentazocine—Dermatitis—Methotrexate—multiple sclerosis	0.000655	0.00103	CcSEcCtD
Pentazocine—Headache—Methotrexate—multiple sclerosis	0.000652	0.00102	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000641	0.00208	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000633	0.00206	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00063	0.00204	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000626	0.00203	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000626	0.00203	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCR2—multiple sclerosis	0.000626	0.00203	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000625	0.00203	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GPR65—multiple sclerosis	0.000622	0.00202	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000618	0.00201	CbGpPWpGaD
Pentazocine—Nausea—Methotrexate—multiple sclerosis	0.000618	0.000967	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000617	0.002	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000604	0.00196	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000604	0.00196	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.000601	0.00195	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GPR65—multiple sclerosis	0.0006	0.00195	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000594	0.00193	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000593	0.00193	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000588	0.00191	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.000585	0.0019	CbGpPWpGaD
Pentazocine—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.000584	0.00189	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CNR1—multiple sclerosis	0.000578	0.00188	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000577	0.00187	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.000575	0.00187	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000572	0.00186	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000569	0.00185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.000569	0.00185	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000563	0.00183	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000563	0.00183	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000549	0.00178	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000549	0.00178	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.000547	0.00178	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.000545	0.00177	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000544	0.00177	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000537	0.00174	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000535	0.00174	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00053	0.00172	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000529	0.00172	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000527	0.00171	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000523	0.0017	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000522	0.00169	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000521	0.00169	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000521	0.00169	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00052	0.00169	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000511	0.00166	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000511	0.00166	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000507	0.00165	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000499	0.00162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000499	0.00162	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000497	0.00161	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000488	0.00158	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000486	0.00158	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000472	0.00153	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000464	0.00151	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000464	0.00151	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000462	0.0015	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000461	0.0015	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.00046	0.00149	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000457	0.00148	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000456	0.00148	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000448	0.00145	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000448	0.00145	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000446	0.00145	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000443	0.00144	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00044	0.00143	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00044	0.00143	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00043	0.00139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000421	0.00137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000421	0.00137	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000415	0.00135	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000414	0.00134	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000412	0.00134	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000405	0.00131	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000405	0.00131	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000404	0.00131	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000404	0.00131	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.0004	0.0013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00039	0.00127	CbGpPWpGaD
Pentazocine—EBP—Metabolism—APOE—multiple sclerosis	0.000389	0.00126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.000389	0.00126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000387	0.00126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000386	0.00125	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000379	0.00123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000377	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000377	0.00122	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000372	0.00121	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000367	0.00119	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000366	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000364	0.00118	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.00036	0.00117	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000355	0.00115	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000354	0.00115	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000352	0.00114	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00035	0.00114	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000342	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000342	0.00111	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000341	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.00034	0.0011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000338	0.0011	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000338	0.0011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000336	0.00109	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000336	0.00109	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000335	0.00109	CbGpPWpGaD
Pentazocine—EBP—Metabolism—POMC—multiple sclerosis	0.000334	0.00108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00033	0.00107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000329	0.00107	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000327	0.00106	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000322	0.00105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000321	0.00104	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000318	0.00103	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000315	0.00102	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000309	0.001	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000307	0.000998	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000305	0.000988	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ALB—multiple sclerosis	0.000305	0.000988	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.0003	0.000974	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000299	0.00097	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000297	0.000962	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000295	0.000956	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000295	0.000956	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000294	0.000954	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000289	0.000938	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000289	0.000937	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000287	0.000932	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000279	0.000906	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000276	0.000896	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000272	0.000883	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000272	0.000881	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000267	0.000866	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000267	0.000865	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.000262	0.000851	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000261	0.000846	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.00026	0.000844	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000256	0.000832	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000253	0.000821	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000251	0.000813	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000249	0.000808	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000249	0.000808	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000249	0.000806	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.000239	0.000777	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000236	0.000766	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000233	0.000755	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.00023	0.000748	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.00023	0.000746	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000228	0.00074	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.000227	0.000736	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000226	0.000732	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000225	0.000729	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.000223	0.000722	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.00022	0.000715	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.000216	0.000702	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000214	0.000694	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	0.00021	0.000681	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	0.000207	0.000672	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000204	0.000662	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.000203	0.00066	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	0.000202	0.000656	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.0002	0.000648	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PGR—multiple sclerosis	0.000199	0.000646	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	0.000195	0.000633	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000194	0.00063	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD28—multiple sclerosis	0.000193	0.000627	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000193	0.000625	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00019	0.000616	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	0.00019	0.000616	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.000185	0.000599	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.000181	0.000586	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.00018	0.000584	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	0.000178	0.000578	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000177	0.000576	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	0.000175	0.000568	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000175	0.000568	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000172	0.00056	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000171	0.000554	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.000168	0.000546	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000165	0.000535	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000164	0.000532	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000163	0.00053	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	0.000162	0.000525	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.00016	0.000521	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	0.000158	0.000514	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	0.000158	0.000512	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.000157	0.00051	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000155	0.000502	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000151	0.000489	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	0.00015	0.000488	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000148	0.00048	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	0.000144	0.000467	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	0.000143	0.000465	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	0.00014	0.000453	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD86—multiple sclerosis	0.000138	0.000448	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	0.000137	0.000446	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000137	0.000444	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	0.000136	0.000443	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	0.000136	0.000441	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.000134	0.000434	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000133	0.000433	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	0.000132	0.000428	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—multiple sclerosis	0.000127	0.000412	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	0.000126	0.000408	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	0.000122	0.000397	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000122	0.000394	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	0.000121	0.000391	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	0.00012	0.000388	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD86—multiple sclerosis	0.000117	0.000378	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	0.000115	0.000372	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD80—multiple sclerosis	0.000115	0.000372	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000111	0.000361	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—multiple sclerosis	0.000111	0.000361	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—multiple sclerosis	0.000109	0.000354	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	0.000107	0.000346	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000106	0.000345	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000104	0.000339	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	0.000103	0.000335	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	0.000102	0.000331	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	0.000101	0.000328	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD80—multiple sclerosis	0.000101	0.000327	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	9.69e-05	0.000314	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—multiple sclerosis	9.56e-05	0.00031	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—multiple sclerosis	9.41e-05	0.000305	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	9.35e-05	0.000304	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	9.15e-05	0.000297	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD80—multiple sclerosis	8.5e-05	0.000276	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	8.49e-05	0.000276	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—multiple sclerosis	8.08e-05	0.000262	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—multiple sclerosis	8.06e-05	0.000262	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	8.02e-05	0.00026	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	7.91e-05	0.000257	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.74e-05	0.000251	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	7.63e-05	0.000248	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	7.18e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—multiple sclerosis	7.07e-05	0.000229	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	7.03e-05	0.000228	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	6.78e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	6.69e-05	0.000217	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—multiple sclerosis	6.3e-05	0.000205	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	6.29e-05	0.000204	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	6.17e-05	0.0002	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—multiple sclerosis	5.97e-05	0.000194	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	5.95e-05	0.000193	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	5.94e-05	0.000193	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	5.65e-05	0.000183	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—multiple sclerosis	5.53e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	5.51e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	5.41e-05	0.000175	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	5.03e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—multiple sclerosis	4.74e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—multiple sclerosis	4.67e-05	0.000152	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.66e-05	0.000151	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.57e-05	0.000148	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—multiple sclerosis	4.15e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—multiple sclerosis	3.51e-05	0.000114	CbGpPWpGaD
